ICU Resource Use in Critically III Patients following Chimeric Antigen Receptor T-Cell Therapy.

Autor: Brown ART; The University of Texas MD Anderson Cancer Center Houston, Texas., Jindani I; The University of Texas MD Anderson Cancer Center Houston, Texas., Melancon J; The University of Texas MD Anderson Cancer Center Houston, Texas., Erfe R; The University of Texas MD Anderson Cancer Center Houston, Texas., Westin J; The University of Texas MD Anderson Cancer Center Houston, Texas., Feng L; The University of Texas MD Anderson Cancer Center Houston, Texas., Gutierrez C; The University of Texas MD Anderson Cancer Center Houston, Texas.
Jazyk: angličtina
Zdroj: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Oct 15; Vol. 202 (8), pp. 1184-1187.
DOI: 10.1164/rccm.202002-0286LE
Databáze: MEDLINE